President Trump announced Thursday that he’s reached a drug pricing deal with Regeneron, the last holdout among the 17 large pharmaceutical companies to agree to most-favored-nation prices in the U.S.![]()
President Trump announced Thursday that he’s reached a drug pricing deal with Regeneron, the last holdout among the 17 large pharmaceutical companies to agree to most-favored-nation prices in the U.S.![]()